Molecular targeting of cancer: telomeres as targets.
Hodes
R
R
National Institutes of Health, Bethesda, MD 20892, USA. hodesr@31.nia.nih.gov
D000818:Animals; D002455:Cell Division / Q000235:genetics; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D018390:Gene Targeting; D015316:Genetic Therapy; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009154:Mutation; D009369:Neoplasms / Q000201:enzymology* / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D009374:Neoplasms, Experimental / Q000201:enzymology / Q000235:genetics / Q000473:pathology / Q000628:therapy; D019098:Telomerase / Q000235:genetics* / Q000378:metabolism*
D004791:Enzyme Inhibitors; D019098:Telomerase